𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Denosumab HALTs bone loss during AI therapy for breast cancer

✍ Scribed by Ebden, L

Book ID
120845241
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2008
Weight
195 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Denosumab and changes in bone turnover m
Denosumab and changes in bone turnover markers during androgen deprivation therapy for prostate cancer
✍ Matthew R Smith; Fred Saad; Blair Egerdie; Paul Sieber; Teuvo LJ Tammela; Benjam πŸ“‚ Article πŸ“… 2011 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 127 KB

## Abstract Androgen deprivation therapy (ADT) for prostate cancer increases fracture risk, decreases bone mineral density, and increases bone turnover markers (BTMs) including serum type 1 C‐telopeptide (sCTX), tartrate‐resistant alkaline phosphatase 5b (TRAP‐5b), and procollagen‐1 N‐terminal telo